Back to Selection     Print       Date : 30 Nov 2025
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-18
Corpus(Cr.) 6460.0 Latest NAV 37.11 As on 29-01-2026
Equity(%) 97.71 52 Week High 41.47
Debt(%) 2.29 52 Week Low 33.8
Others(%) 0.0 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.86
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 44.16%
Top 10 Holdings 64.33%
Top 25 Holdings 88.96%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 85.35
Healthcare 7.14
Miscellaneous 2.71
Cash 2.29
Retail 1.34
Chemicals 1.17
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.16
PE Ratio 0.00
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 12.83
Dr Reddys Laboratories Limited 9.81
Cipla Limited 8.00
DIVI LABORATORIES LTD. 7.48
Aurobindo Pharma Limited 6.04
Lupin Limited 5.70
Mankind Pharma Limited 5.04
Alkem Laboratories Limited 3.78
Syngene International Limited 2.97
Cohance Lifesciences Limited 2.68
Zydus Lifesciences Limited 2.57
TREPS 2.23
Biocon Limited 2.20
Thyrocare Technologies Limited 2.15
ALEMBIC PHARMACEUTICALS 1.85
Medi Assist Healthcare Services Limited 1.59
J B Chemicals and Pharma Ltd 1.59
Gland Pharma Limited 1.57
Blue Jet Healthcare Limited 1.41
Pfizer Limited 1.39
Medplus Health Services Limited 1.34
Metropolis Healthcare Limited 1.31
EQ -FINE ORGANIC IND LTD 1.17
Glenmark Pharmaceuticals Limited 1.14
Star Health & Allied Insurance 1.12

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-5.91% -8.44% -10.36% 1.48%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-1.95% -2.33% 2.82% 11.06%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-5.17% -7.63% -8.31% 2.09%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
14.01% 25.39% 16.96% 0.00%
 
 
9.44% 14.31% 14.62% 14.28%
 
 
11.76% 21.05% 14.74% 8.72%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 15.68% 1.4279 10.3854% 42.3545 0.1811
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ICICI Pru Pharma Healthcare And Diagnostics Fund (G) 16.6708% 0.0002 0.3598 13.6655 1.1943
 
Back to Selection